# A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)

> **NCT06814119** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 34 (actual)

## Conditions studied

- Healthy
- Renal Impairment

## Interventions

- **DRUG:** Calderasib

## Key facts

- **NCT ID:** NCT06814119
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-07
- **Primary completion:** 2026-01-23
- **Final completion:** 2026-02-06
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06814119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06814119, "A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06814119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*